Can a traditional chinese herbal remedy stop stroke patients from getting worse?
NCT ID NCT06857487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a traditional Chinese herbal formula called Qingre Huatan can prevent early neurological deterioration in people who have had an acute ischemic stroke within the last 48 hours. The trial will involve 72 participants, who will receive either the herbal granules or a placebo twice daily for 10 days, alongside standard stroke care. The main goal is to see if the formula reduces the risk of worsening symptoms within the first week.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Qingre Huatan formula (herbal granules)
What this could lead to
If it works, this could offer a new way to prevent early neurological decline after a stroke, potentially reducing long-term disability.
What could go wrong
This is a small, early-phase pilot trial with only 72 participants, so results may not be conclusive. The herbal formula may not outperform placebo, and individual responses can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dongzhimen Hospital
RECRUITINGBeijing, Beijing Municipality, 100700, China
Contact Phone: •••-•••-•••• Email: •••••@•••••